Home › Funds › Jefferies Financial Group Inc. › URGN

Jefferies Financial Group Inc. position in URGN

UROGEN PHARMA LTD · Health Care

Jefferies Financial Group Inc. reported holding 2,199,652 shares of URGN (UROGEN PHARMA LTD) in its Q3 2026 13F filing — a position valued at US$89.4M, representing 1.64% of its reported portfolio and ranking #6 among its reported holdings. Jefferies Financial Group Inc. has disclosed URGN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)2.20M sh
Reported value held$89.37M
Portfolio Weight1.64%
First reportedQ1 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Jefferies Financial Group Inc.'s URGN position evolved

Jefferies Financial Group Inc. first disclosed a stake in URGN in Q1 2024 at 840,000 shares (US$12.6M). The position peaked in Q3 2026 at 2,199,652 shares, worth US$89.4M. Across 11 filings, Jefferies Financial Group Inc. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,199,652 shares valued at US$89.4M. Notable position changes include a 96% trim in Q2 2025 (shares rose 46% over the following quarter), a 7232% increase in Q3 2025 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 840.00K $12.60M New
Q2 2024 965.00K $16.19M Add
Q3 2024 965.00K $12.26M Hold
Q4 2024 965.93K $10.29M Hold
Q1 2025 815.00K $9.01M Reduce
Q2 2025 30.00K $411.00K Reduce
Q3 2025 2.20M $43.88M Add
Q4 2025 2.20M $51.52M Hold
Q1 2026 2.20M $39.55M Hold
Q2 2026 2.20M $80.95M Hold
Q3 2026 2.20M $89.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About URGN and 13F data

URGN (UROGEN PHARMA LTD) is a Health Care company. 44 other funds we track also report a position in URGN — the largest reported positions include RTW INVESTMENTS, LP (US$167.2M), Kynam Capital Management, LP (US$89.6M), ACORN CAPITAL ADVISORS, LLC (US$61.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding URGN

All URGN fund holders →

FAQ

How long has Jefferies Financial Group Inc. held URGN?

Jefferies Financial Group Inc. has disclosed URGN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Jefferies Financial Group Inc.'s current position in URGN?

As of Q3 2026, Jefferies Financial Group Inc. holds 2.20M shares of URGN (UROGEN PHARMA LTD), valued at $89.37M, representing 1.64% of its reported portfolio and ranking #6.

Has Jefferies Financial Group Inc. been buying or selling URGN?

In the latest 13F filing (Q3 2026), Jefferies Financial Group Inc. held unchanged its position in URGN. The position peaked in Q3 2026 at 2.20M shares.

Which other funds hold URGN?

Other major institutional holders of URGN include RTW INVESTMENTS, LP, Kynam Capital Management, LP, ACORN CAPITAL ADVISORS, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.